GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: StockDung	6/23/2009 9:12:54 AM
	of 5582

GUM DE GUM GUM->SEC launches informal inquiry into Matrixx Jun 23, 2009, 8:26 a.m. EST marketwatch.com BOSTON (MarketWatch) -- The Securities and Exchange Commission has launched an informal inquiry into Matrixx Initiatives' (MTXX 4.89, -0.36, -6.86%) handling of a warning letter issued by the Food and Drug Administration last week over its Zicam cold remedy products, according to a federal filing made Tuesday. The company received a letter of inquiry from the SEC on June 19. On June 16, the FDA warned consumers not to use certain Zicam nasal products over concerns that they could permanently damage users' sense of smell. The Zicam products, which are considered homeopathic in nature, are not FDA-approved. marketwatch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next